News - Eisai, Patents

Filter

Current filters:

EisaiPatents

Popular Filters

European Alzheimer's drug market to grow to $4.78 billion by 2019, says F&S

25-11-2012

The patent expiry of all four existing European Medicines Agency-approved drugs for Alzheimer's disease…

AriceptEbixaEisaiEuropeExelon PatchLundbeckMarkets & MarketingNeurologicalNovartisPatentsPharmaceuticalResearch

Eisai wins patent extension in Japan for blockbuster Alzheimer’s drug Aricept

15-09-2011

Japanese drug major Eisai (TYO: 4523) says that the Supreme Court of Japan has turned down a petition…

AriceptAsia-PacificEisaiGenericsNeurologicalPatentsPharmaceutical

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top